| Literature DB >> 30178072 |
Roxanne Gal1, Anne M May2, Elon J van Overmeeren2, Monique Simons3, Evelyn M Monninkhof2.
Abstract
BACKGROUND: Worldwide physical activity levels of adults are declining, which is associated with increased chronic disease risk. Wearables and smartphone applications offer new opportunities to change physical activity behaviour. This systematic review summarizes the evidence regarding the effect of wearables and smartphone applications on promoting physical activity.Entities:
Keywords: Physical activity; Smartphone applications; Wearables
Year: 2018 PMID: 30178072 PMCID: PMC6120856 DOI: 10.1186/s40798-018-0157-9
Source DB: PubMed Journal: Sports Med Open ISSN: 2198-9761
Fig. 1Flow diagram of trial selection, adapted from PRISMA. PA physical activity, RCT randomized controlled trial
Characteristics of included studies
| Study | Population | Intervention | Behaviour change techniques | Duration of intervention | Control | |
|---|---|---|---|---|---|---|
| Li et al. [ | Patients with knee osteoarthritis, > 50 years of age | 34/55.5/82 | Individualized PA goals | Self-monitoring | 1 month | Waiting list (same intervention with 1-month delay) |
| Lyons et al. [ | Overweight, inactive adults, aged 55–79 years | 40/61.5/85 | Daily and weekly step goals | Self-monitoring | 12 weeks | Waiting list (full intervention after final assessment) |
| Bickmore et al. [ | Community-dwelling inactive adults, ≥ 65 years of age | 263/71.3/61 | Individualized short- and long-term PA goals | Self-monitoring | 12 months (2 months intervention phase + 10 months maintenance phase) | Wearing pedometer |
| Allen et al. [ | Overweight adults, aged 21–65 years | 34/44.9/78 | PA goal of ≥ 150 min/week of MVPA | Self-monitoring | 6 months | Intensive counselling |
| Demeyer et al. [ | COPD patients, > 40 years of age, smoking history ≥ 10 pack-years, stable or having an exacerbation in the last month | 343/67/36 | Individualized daily PA (step) goals | Self-monitoring | 12 weeks | Usual care (standard leaflet explaining the importance of PA, information about PA recommendations) |
| Shin et al. [ | Overweight Korean male university students, aged 19–45 years | 70/27.8/0 | Individualized PA goal to lose weight | Self-monitoring | 12 weeks | Brief education sessions on diet and exercise and education materials |
| Recio-Rodriguez et al. [ | Adults, ≤ 70 years of age, from Spanish primary care centres | 833/51.9/62 | Standardized counselling in PA and the Mediterranean diet | Self-monitoring | 3 months | Standardized counselling |
| Uhm et al. [ | Patients, aged 20–70 years, who completed primary breast cancer treatment | 356/50.3/100 | PA goal of ≥ 150 min/week of MVPA | Self-monitoring | 12 weeks | PA goal of ≥ 150 min/week of MVPA |
| Glynn et al. [ | Primary care patients | 90/44.1/64 | PA goal of 10,000 steps/day | Self-monitoring | 8 weeks | PA goal of 30 min walking/day |
| Fukuoka et al. [ | Overweight, inactive adults, ≥ 35 years of age, at risk for diabetes | 61/55.2/77 | Long-term PA goal of 12,000 steps/day | Self-monitoring | 5 months | Wore pedometer, displaying step count |
| Safran Naimark et al. [ | Healthy adults interested in a healthy lifestyle | 99/47.9/64 | Presentation on healthy lifestyle | Self-monitoring | 14 weeks | Presentation on a healthy lifestyle |
| Martin et al. [ | Adults visiting a cardiovascular disease prevention centre | 32/58.0/46 | PA goal of 10,000 steps/day | Self-monitoring | 4 weeks (2 weeks phase 1 and 2 weeks phase 2) | Blinded digital activity tracking |
| Walsh et al. [ | Young adults, aged 17–26 years, using a mobile phone | 58/20.5/73 | PA goal of 10,000 steps/day | Self-monitoring | 5 weeks | Education regarding PA goal of 30 min walking/day and benefits |
| Hartman et al. [ | Middle-aged and older overweight women with elevated breast cancer risk | 55/59.5/100 | Weight loss intervention with MyFitnessPal and Fitbit app | Self-monitoring | 6 months | Usual care (dietary guidelines) |
| Harries et al. [ | Healthy males, aged 22–40 years | 110/NA/0 | Smartphone app recording steps and providing feedback | Self-monitoring | 6 weeks (plus 2 weeks run-in) | Carries smartphone to record steps with a built-in accelerometer |
| Vorrink et al. [ | Patients with COPD, GOLD stage 2 or 3, ≥ 40 years of age | 183/63.0/50 | Individualized PA goal | Self-monitoring | 12 months | Usual care |
| King et al. [ | Underactive adults, ≥ 45 years of age, with no prior smartphone experience | 49/60.0/75 | Daily PA goal of 30 min/day of MVPA | Self-monitoring | 8 weeks | Non-physical, diet-tracking control app (Calorific) |
| Paul et al. [ | Stroke survivors | 24/56.0/52 | Individualized PA step goals, increased during the intervention period | Self-monitoring | 6 weeks | Usual care (wore ActivPAL before start intervention and during last week) |
COPD chronic obstructive pulmonary disease, ECA computer-animated virtual exercise coach, GOLD Global Initiative for Chronic Obstructive Lung Disease, MVPA moderate-to-vigorous physical activity, PA physical activity
Measurement of physical activity outcome
| Study | Physical activity outcome | Outcome measurement instrument | Timing of measurement | Objective/subjective |
|---|---|---|---|---|
| Li et al. [ | MVPA, ≥ 4 METs (min/day) | SenseWear Mini armband (research-based accelerometer) | Baseline and 1 month | Objective |
| Lyons et al. [ | Stepping time (min/day) | ActivPAL activity monitor | Baseline and 12 weeks (and 6 weeks) | Objective |
| Bickmore et al. [ | Steps/day | Digital pedometer | 12 months (and 2 months) | Objective |
| Allen et al. [ | MVPA (hours/week) | Stanford 7-day Physical Activity Recall (PAR) questionnaire | Baseline and 6 months | Subjective |
| Demeyer et al. [ | MPA (min/day) | ActiGraph GT3X+ accelerometer | Baseline and 12 weeks | Objective |
| Shin et al. [ | Kcal/day | International Physical Activity Questionnaire-Short Form (IPAQ-SF) | Baseline and 12 weeks | Subjective |
| Recio-Rodriguez et al. [ | MVPA (min/week) | ActiGraph GT3X accelerometer | Baseline and 3 months | Objective |
| Uhm et al. [ | MET/week | International Physical Activity Questionnaire-Short Form (IPAQ-SF) | Baseline and 12 weeks | Subjective |
| Glynn et al. [ | Steps/day | Accupedo Pro Pedometer App | Baseline and week 8 (and week 2) | Objective |
| Fukuoka et al. [ | MPA (min/day) | Omron Active Style Pro HJA-350IT pedometer | Baseline and 5 months (and every month) | Objective |
| Safran Naimark et al. [ | PA (min/week) | Questionnaire-based on the International Physical Activity Questionnaire (IPAQ) | Baseline and 14 weeks | Subjective |
| Martin et al. [ | MVPA (min/day) | Fitbug Orb accelerometer | Baseline and 5 weeks | Objective |
| Walsh et al. [ | Steps/day | Accupedo-Pro Pedometer App | Baseline and 5 weeks | Objective |
| Hartman et al. [ | MVPA (min/day) | ActiGraph GT3X+ accelerometer | Baseline (week before randomization) and 6 months | Objective |
| Harries et al. [ | Steps/day | Smartphone app bActive with a built-in accelerometer | Continuously during the trial. Mean number of steps in the 6th week is used. | Objective |
| Vorrink et al. [ | Steps/day | SenseWear Mini armband (research-based accelerometer) | Baseline and 12 months (and 3 months and 6 months) | Objective |
| King et al. [ | MVPA (min/day) | Smartphone-based accelerometer | Unknown | Objective |
| Paul et al. (2016) [ | Steps/day | ActivPAL™ activity monitor | Baseline (7 days before the start of the intervention) and the last 7 days of the intervention period | Objective |
Kcal kilocalorie, MET metabolic equivalent of task, min minutes, MPA moderate physical activity, MVPA moderate-to-vigorous physical activity, PA physical activity
Fig. 2Risk of bias graph: review authors’ judgements about each risk of bias item presented as percentages across all included studies
Fig. 3Risk of bias summary: review authors’ judgements about each risk of bias item for each included study. Green symbols represent a low risk of bias, yellow symbols represent an unclear risk of bias and the red symbols indicate a high risk of bias
Fig. 4Forest plot of the effect of wearables and smartphone applications versus control on moderate-to-vigorous physical activity (MVPA) in minutes per day. CI confidence interval, IV inverse variance, RoB risk of bias, SD standard deviation, Std standardized
Fig. 5Forest plot of the effect of wearables and smartphone applications versus control on daily step count. CI confidence interval, IV inverse variance, RoB risk of bias, SD standard deviation, Std standardized
Fig. 6Forest plot of the effect of wearables and smartphone applications versus control on other outcomes. CI confidence interval, IV inverse variance, MET metabolic equivalent of task, SD standard deviation, Std standardized